Incidence of bleeding complications in pediatric patients with type 1 von Willebrand disease undergoing adenotonsillar procedures

J Pediatr. 2009 Jul;155(1):68-72. doi: 10.1016/j.jpeds.2009.01.051. Epub 2009 Apr 24.

Abstract

Objective: To review the incidence of postoperative bleeding in children with type 1 von Willebrand disease (VWD) who were treated with a single institution protocol.

Study design: We performed a retrospective study to determine the postoperative hemorrhage rate in pediatric patients with type 1 VWD who were treated via the Children's Hospital of Philadelphia institutional protocol. This protocol utilizes intravenous desmopressin (DDAVP), oral aminocaproic acid, and overnight observation.

Results: Between the years of 2000 to 2006, 41 children with type 1 VWD underwent an adenotonsillar procedure and were treated with this protocol. Seven patients (17%) experienced delayed (>24 hours after surgery) postoperative hemorrhage requiring intervention. Five of the 7 patients required cautery to control the bleeding, and the remaining 2 patients responded to DDAVP and aminocaproic acid alone. Older age and lower VW antigen levels were associated with postoperative hemorrhage (P = .05).

Conclusions: Despite therapeutic intervention to decrease the risk of postoperative hemorrhage, the incidence of hemorrhage was higher in pretreated patients with type 1 VWD than in children without bleeding disorders. Further prospective studies are necessary to determine the optimal treatment to reduce bleeding complications in these patients.

MeSH terms

  • Adenoidectomy*
  • Administration, Oral
  • Adolescent
  • Age Factors
  • Aminocaproates / therapeutic use
  • Cautery
  • Child
  • Child, Preschool
  • Deamino Arginine Vasopressin / therapeutic use
  • Female
  • Hemostatics / therapeutic use
  • Humans
  • Infusions, Intravenous
  • Male
  • Postoperative Hemorrhage / epidemiology*
  • Postoperative Hemorrhage / prevention & control*
  • Postoperative Nausea and Vomiting / epidemiology
  • Retrospective Studies
  • Tonsillectomy*
  • von Willebrand Diseases / epidemiology*
  • von Willebrand Diseases / immunology
  • von Willebrand Factor / analysis
  • von Willebrand Factor / immunology

Substances

  • Aminocaproates
  • Hemostatics
  • Von Willebrand antigen
  • von Willebrand Factor
  • Deamino Arginine Vasopressin